A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants

被引:19
|
作者
Li, Xuanyi [1 ]
Warner, Jeremy L. [2 ,3 ]
机构
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA
[3] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA
关键词
precision oncology; knowledgebase; variant interpretation; actionability; targeted therapy; genotype-selective clinical trial; tumor genetic testing; OFF-LABEL USE; PRIVATE MUTATIONS; PHARMACOGENOMICS KNOWLEDGE; MEDICINE; GENOMICS; TRIAL; IDENTIFICATION; INFORMATION; PREVALENCE; LANDSCAPE;
D O I
10.3389/fcell.2020.00048
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The increased availability of tumor genetic testing and targeted cancer therapies contributes to the advancement of precision medicine in the field of oncology. Precision oncology knowledgebases provide a way of organizing clinically relevant genetic information in a way that is easily accessible for both oncologists and patients, facilitating the genetic-based clinical decision making. Many organizations and companies have built precision oncology knowledgebases, intended for multiple users. In general, these knowledgebases offer information on cancer-related genetic variants as well as their associated diagnostic, prognostic, and therapeutic implications, but they often differ in their information curations, designs, and user experiences. It is advisable that oncologists use multiple knowledgebases during their practice to have them complement each other. In the future, convergence toward common standards and formats is needed to ensure that the comprehensive knowledge across all sources can be unified to bring the oncology community closer to the achievement of the goal of precision oncology.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Precision Oncology in Clinical Practice in Japan
    Muto, Manabu
    ANNALS OF ONCOLOGY, 2019, 30 : 3 - 3
  • [32] Precision oncology: a clinical and patient perspective
    Lassen, Ulrik N.
    Makaroff, Lydia E.
    Stenzinger, Albrecht
    Italiano, Antoine
    Vassal, Gilles
    Garcia-Foncillas, Jesus
    Avouac, Bernard
    FUTURE ONCOLOGY, 2021, 17 (30) : 3995 - 4009
  • [33] The Challenge of Genetic Variants of Uncertain Clinical Significance A Narrative Review
    Burke, Wylie
    Parens, Erik
    Chung, Wendy K.
    Berger, Sara M.
    Appelbaum, Paul S.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (07) : 994 - +
  • [34] Towards Precision Oncology: The Role of Smoothened and Its Variants in Cancer
    Nicheperovich, Alina
    Townsend-Nicholson, Andrea
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (10):
  • [35] Precision oncology targeting FGFRs: A systematic review on pre-clinical activity and clinical outcomes of pemigatinib
    Gnagni, Ludovica
    Ruscito, Ilary
    Zizzari, Ilaria Grazia
    Nuti, Marianna
    Napoletano, Chiara
    Rughetti, Aurelia
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 202
  • [36] Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review
    Rahman, Belinda
    McEwen, Alison
    Phillips, Jane L.
    Tucker, Katherine
    Goldstein, David
    Jacobs, Chris
    PERSONALIZED MEDICINE, 2021, 19 (02) : 139 - 153
  • [37] Genetic variants and clinical manifestations in familial atrial fibrillation: a systematic review
    van Keulen, Maxime
    Wijdeveld, Leonoor
    Dooijes, Dennis
    van Spaendonck-Zwarts, Karin
    Brundel, Bianca
    van Tintelen, Peter
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1018 - 1019
  • [38] Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
    Tomczak, Aurelie
    Springfeld, Christoph
    Dill, Michael T.
    Chang, De-Hua
    Kazdal, Daniel
    Wagner, Ursula
    Mehrabi, Arianeb
    Brockschmidt, Antje
    Luedde, Tom
    Naumann, Patrick
    Stenzinger, Albrecht
    Schirmacher, Peter
    Longerich, Thomas
    BRITISH JOURNAL OF CANCER, 2022, 127 (09) : 1701 - 1708
  • [39] Progress and impact of clinical phosphoproteomics on precision oncology
    Lima, Nadia
    Lee, Alex T. J.
    Huang, Paul H.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S1108 - S1114
  • [40] Clinical Use of Precision Oncology Decision Support
    Johnson, Amber
    Khotskaya, Yekaterina B.
    Brusco, Lauren
    Zeng, Jia
    Holla, Vijaykumar
    Bailey, Ann M.
    Litzenburger, Beate C.
    Sanchez, Nora S.
    Abu Shufean, Md
    Piha-Paul, Sarina
    Subbiah, Vivek
    Hong, David
    Routbort, Mark
    Broaddus, Russell
    Shaw, Kenna R. Mills
    Mills, Gordon B.
    Mendelsohn, John
    Meric-Bernstam, Funda
    JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 12